Parecoxib
Specifications
198470-84-7CAS Number
803-261-6EC Number
N-[4-(5-methyl-3-phenyl-1,2-oxazol-4-yl)phenyl]sulfonylpropanamideIUPAC Name
C19H18N2O4SChemical Formula
370.4 g/molMolecular Weight
Parecoxib; 198470-84-7; Xapit; SC-69124; SC 69124; Rayzon; parecoxibum; 9TUW81Y3CE; N-((p-(5-methyl-3-phenyl-4-isoxazolyl)phenyl)sulfonyl)propionamide; Propanamide, N-[[4-(5-methyl-3-phenyl-4-isoxazolyl)phenyl]sulfonyl]-; CHEBI:73038; N-[4-(5-methyl-3-phenyl-1,2-oxazol-4-yl)phenyl]sulfonylpropanamide; DTXSID1044229; Propanamide, N-((4-(5-methyl-3-phenyl-4-isoxazolyl)phenyl)sulfonyl)-; N-{[4-(5-methyl-3-phenyl-1,2-oxazol-4-yl)phenyl]sulfonyl}propanamide; N-((4-(5-methyl-3-phenyl-1,2-oxazol-4-yl)phenyl)sulfonyl)propanamide; N-(4-(5-methyl-3-phenyl-1,2-oxazol-4-yl)phenyl)sulfonylpropanamide; RefChem:858667; DTXCID9024229; N-(((Me-P)-P)S)P; M01AH04; N-(((5-methyl-3-phenylisoxazol-4-yl)-phenyl)sulfonyl)propanamine, sodium salt; N-(((5-methyl-3-phenylisoxazol-4-yl)-phenyl)sulfonyl)propanamide; N-[4-(5-methyl-3-phenyl-1,2-oxazol-4-yl)benzenesulfonyl]propanamide; N-((4-(5-methyl-3-phenylisoxazol-4-yl)phenyl)sulfonyl)propionamide; MFCD08141856; n-[[4-(5-methyl-3-phenyl-4-isoxazolyl)phenyl]sulfonyl]propanamide; Parecoxib [USAN:INN:BAN]; Valus-P; Vorth-P; Propanamide, N-[[4-(5-methyl-3-phenyl-4-isoxazolyl)phenyl]sulfonyl]-; N-[[4-(5-Methyl-3-phenyl-4-isoxazolyl)phenyl]sulfonyl]propanamide; Parecoxib; SC 69124; Valus-P; Vorth-P; Parecoxib (Standard); PARECOXIB [INN]; PARECOXIB [MI]; Parecoxib (USAN/INN); PARECOXIB [USAN]; UNII-9TUW81Y3CE; PARECOXIB [WHO-DD]; SCHEMBL9529; PARECOXIB [EMA EPAR]; Parecoxib Sodium Impurity 81; GTPL2895; orb1225771; orb1307460; CHEMBL1206690; TZRHLKRLEZJVIJ-UHFFFAOYSA-N; HMS3741C09; HMS3885L14; HMS5083C10; EX-A1993; BDBM50506744; EBC-26824; HY-17474R; MSK161136; s4656; AKOS025401810; CCG-268299; CS-1959; DB08439; NCGC00181773-03; NCGC00181773-04; NCGC00181773-05; NCGC00378576-02; Parecoxib 100 microg/mL in Acetonitrile; AC-25842; AS-72353; HY-17474; NS00004159; Parecoxib, VETRANAL(TM), analytical standard; D03716; EN300-20600171; F862138; Q347941; BRD-K13800121-001-01-5; BRD-K13800121-236-01-7; Z2588040125; N-[4-(5-methyl-3-phenyl-isoxazol-4-yl)phenyl]sulfonylpropanamide; N-{[4-(5-methyl-3-phenylisoxazol-4-yl)phenyl]sulfonyl}propanamide; N-[[4-(5-methyl-3-phenyl-4-isoxazolyl) phenyl] sulfonyl] propanamide; N-[4-(5-Methyl-3-phenyl-1,2-oxazol-4-yl)benzene-1-sulfonyl]propanamide; N-?[[4-?(5-?Methyl-?3-?phenyl-?4-?isoxazolyl)?phenyl]?sulfonyl]?propanamide; PXBSynonyms